Charles Schwab Investment Management Inc. increased its position in Natera Inc (NASDAQ:NTRA) by 27.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Co
Wall Street analysts predict that Natera Inc (NASDAQ:NTRA) will post $78.88 million in sales for the current quarter, Zacks reports. Four analysts have issued estimates for Natera’s earnings. The lo
SAN CARLOS, Calif. , March 4, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA ), a pioneer and global leader in cell-free DNA testing, today announced it will be participating in the Cutting Edge of T
Acadian Asset Management LLC purchased a new position in shares of Natera Inc (NASDAQ:NTRA) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Ex
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast live presentations at the Cowen and Company 40th Annual Health Care Conference i
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that its Prospera donor-derived cell-free DNA (dd-cfDNA) test has been priced favorably at $2,840.75.
Advisory Research Inc. increased its position in shares of Natera Inc (NASDAQ:NTRA) by 32.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 35,645
Natera Inc (NASDAQ:NTRA) – Research analysts at Piper Sandler issued their Q1 2021 earnings per share estimates for Natera in a note issued to investors on Wednesday, February 26th. Piper Sandler an

Should You Buy These 2 Prenatal Testing Stocks?

01:07pm, Saturday, 29'th Feb 2020
More babies are born in summer and early fall than other times of year, meaning mothers-to-be are likely undergoing prenatal testing now. Can investors profit?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Natera Inc (NASDAQ:NTRA)’s share price rose 7.1% during mid-day trading on Thursday following a better than expected earnings announcement. The company traded as high as $40.00 and last traded at $3
Canaccord Genuity analyst Max Masucci reiterated a Buy rating on Natera (NTRA) today and set a price target of $46.00. The company's shares closed last
Canaccord Genuity analyst Max Masucci reiterated a Buy rating on Natera ( NTRA – Research Report ) today and set a price target of $46.00 . The company’s shares closed last Monday at $34.77. Accor
Naturally Splendid Enterprises Ltd (CVE:NSP)’s share price reached a new 52-week low during trading on Tuesday . The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 14365

Natera (NTRA) Q4 2019 Earnings Call Transcript

09:01am, Thursday, 27'th Feb 2020
NTRA earnings call for the period ending December 31, 2019.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE